Cumberland Pharmaceuticals Inc (CPIX) Annual Balance Sheets

Annual · GAAP · USD millions
Access CPIX quarterly Balance Sheets →
Changes in quarterly balance sheet trends offer perspective on how Cumberland Pharmaceuticals Inc balances growth, leverage, and shareholder equity.
Annual Report, GAAP in USD millions
ITEM
(Dec 31 2025)
(Dec 31 2024) (Dec 31 2023) (Dec 31 2022) (Dec 31 2021)
Assets
Cash & cash equivalent11.44
Cash & Short-term Investments11.00
Accounts receivable16.94
Inventories6.23
Prepaid Expense And Other Assets Current2.45
Total Current Assets37.06
Equipment/Property/Plant Net0.26
Goodwill net0.91
Intangible Assets14.03
Other Assets, Noncurrent20.57
Operating Lease Right Of Use Asset8.34
Total Assets76.82
Liabilities
Accounts Payable, Current AC18.57
Accrued Liabilities, Current AC0.00
Long-term Debt, Current Maturities LO0.00
Other Liabilities, Current18.18
Total Current Liabilities36.74
Long-term debt5.24
Total Long-term Debt5.24
Other liabilities, Noncurrent5.82
Operating Lease Liability Current0.47
Operating Lease Liability Noncurrent4.47
Total Liabilities52.28
Stockholders' Equity
Common Stock Value51.68
Retained Earnings / Accumulated Deficit-26.80
Other Equity0.00
Common Stockholder's Equity24.88
Non-controlling interests & other-0.34
Total Stockholder's Equity24.54
Liabilities & Stockholder's Equity76.82
4 historic quarters locked

Sign in to unlock the full Cumberland Pharmaceuticals Inc balance sheet history.

About Cumberland Pharmaceuticals Inc Annual Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC 10-K filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.
  • Accession: 0001087294-26-000020

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.